John babich

President & Chief Scientific Officer Ratio Therapeutics

Seminars

Wednesday 12th November 2025
Panel Discussion – Challenges & Opportunities for Securing Ongoing Funding for Radiopharmaceuticals
9:30 am
  • Assessing differences in US and European markets  
  • Understanding the nuances in European market to appreciate what investors are looking for 
  • Hearing directly from investors about their priorities to secure new funding 
Wednesday 12th November 2025
End of Scientific Programme Day Two
4:40 pm
Wednesday 12th November 2025
Chair’s Opening Remarks
8:50 am
John Babich, President & Chief Scientific Officer, Ratio Therapeutics